Scotiabank lowered the firm’s price target on AvePoint (AVPT) to $12 from $13 and keeps an Outperform rating on the shares. The company reported “solid” Q1 ARR, though the firm had hoped for a more “explosive” beat tot better de-risk the full-year ARR guide, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVPT:
- AvePoint price target lowered to $14 from $16 at Baird
- AvePoint: Solid Q1 and Strengthening AI Positioning, But FX Headwinds and Valuation Keep Rating at Hold as Price Target Cut to $14
- AvePoint investors back board slate, pay packages and auditor at 2026 meeting
- AvePoint reports Q1 EPS 7c, consensus 8c
- AvePoint sees Q2 revenue $120.3M-$122.3M, consensus $124.62M